News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
191,102 Results
Type
Article (8624)
Company Profile (85)
Press Release (182393)
Multimedia
Podcasts (3)
Webinars (6)
Section
Business (59772)
Career Advice (170)
Deals (9803)
Drug Delivery (9)
Drug Development (24956)
Employer Resources (15)
FDA (3413)
Job Trends (3481)
News (97772)
Policy (6850)
Tag
Academia (792)
Academic (1)
Accelerated approval (1)
Adcomms (1)
Allergies (15)
Alliances (20910)
ALS (34)
Alzheimer's disease (527)
Antibody-drug conjugate (ADC) (54)
Approvals (3465)
Artificial intelligence (169)
Autoimmune disease (9)
Automation (7)
Bankruptcy (46)
Best Places to Work (2925)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (67)
Bladder cancer (27)
Brain cancer (9)
Breast cancer (112)
Cancer (987)
Cardiovascular disease (46)
Career advice (158)
Career pathing (8)
CAR-T (45)
Cell therapy (131)
Clinical research (20629)
Collaboration (554)
Company closure (2)
Compensation (123)
Complete response letters (5)
COVID-19 (479)
CRISPR (27)
C-suite (143)
Cystic fibrosis (33)
Data (1052)
Decentralized trials (1)
Denatured (2)
Depression (13)
Diabetes (89)
Diagnostics (1390)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (104)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (35)
Earnings (19955)
Editorial (5)
Employer branding (1)
Employer resources (13)
Events (27321)
Executive appointments (283)
FDA (3873)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (349)
Gene editing (39)
Generative AI (15)
Gene therapy (106)
GLP-1 (225)
Government (610)
Grass and pollen (1)
Guidances (65)
Healthcare (3965)
HIV (10)
Huntington's disease (12)
IgA nephropathy (12)
Immunology and inflammation (42)
Immuno-oncology (1)
Indications (9)
Infectious disease (511)
Inflammatory bowel disease (58)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (39)
Interviews (18)
IPO (4270)
IRA (5)
Job creations (742)
Job search strategy (145)
Kidney cancer (3)
Labor market (10)
Layoffs (76)
Leadership (3)
Legal (1516)
Liver cancer (26)
Longevity (5)
Lung cancer (150)
Lymphoma (66)
Machine learning (8)
Management (7)
Manufacturing (113)
MASH (16)
Medical device (1946)
Medtech (1948)
Mergers & acquisitions (5785)
Metabolic disorders (198)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (45)
Neuropsychiatric disorders (2)
Neuroscience (756)
NextGen: Class of 2025 (1156)
Non-profit (989)
Now hiring (9)
Obesity (94)
Opinion (57)
Ovarian cancer (37)
Pain (20)
Pancreatic cancer (34)
Parkinson's disease (76)
Partnered (8)
Patents (80)
Patient recruitment (47)
Peanut (4)
People (17117)
Pharmaceutical (15)
Pharmacy benefit managers (1)
Phase I (6984)
Phase II (8741)
Phase III (6596)
Pipeline (604)
Policy (23)
Postmarket research (566)
Preclinical (3250)
Press Release (39)
Prostate cancer (33)
Psychedelics (2)
Radiopharmaceuticals (92)
Rare diseases (122)
Real estate (1581)
Recruiting (4)
Regulatory (5355)
Reports (11)
Research institute (954)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (4)
RSV (7)
Schizophrenia (27)
Series A (69)
Series B (41)
Service/supplier (3)
Sickle cell disease (10)
Special edition (2)
Spinal muscular atrophy (76)
Sponsored (9)
Startups (1376)
Stomach cancer (1)
Supply chain (18)
Tariffs (7)
The Weekly (1)
Vaccines (124)
Venture capital (18)
Weight loss (31)
Women's health (7)
Worklife (3)
Date
Today (27)
Last 7 days (144)
Last 30 days (515)
Last 365 days (9115)
2025 (5285)
2024 (10608)
2023 (12486)
2022 (17446)
2021 (17453)
2020 (15376)
2019 (11524)
2018 (8753)
2017 (9677)
2016 (8828)
2015 (10405)
2014 (7585)
2013 (6233)
2012 (6839)
2011 (7192)
2010 (6644)
Location
Africa (196)
Alabama (17)
Alaska (3)
Arizona (25)
Arkansas (2)
Asia (26749)
Australia (3434)
California (2177)
Canada (692)
China (421)
Colorado (61)
Connecticut (131)
Delaware (122)
Europe (30421)
Florida (194)
Georgia (30)
Idaho (6)
Illinois (125)
India (19)
Indiana (184)
Iowa (3)
Japan (160)
Kansas (16)
Kentucky (1)
Louisiana (4)
Maine (10)
Maryland (341)
Massachusetts (1906)
Michigan (15)
Minnesota (87)
Missouri (45)
Montana (11)
Nebraska (3)
Nevada (5)
New Hampshire (6)
New Jersey (607)
New Mexico (12)
New York (615)
North Carolina (216)
North Dakota (3)
Northern California (1072)
Ohio (41)
Oklahoma (5)
Oregon (6)
Pennsylvania (292)
Puerto Rico (2)
Rhode Island (12)
South America (235)
South Carolina (3)
Southern California (773)
Tennessee (29)
Texas (247)
United States (7707)
Utah (52)
Virginia (77)
Washington D.C. (12)
Washington State (151)
Wisconsin (26)
191,102 Results for "horizon discovery ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform.
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
April 1, 2025
·
1 min read
Press Releases
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
March 24, 2025
·
2 min read
Press Releases
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
April 1, 2025
·
1 min read
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Director/PCA Dealing
July 1, 2025
·
3 min read
Press Releases
Kairos Pharma Ltd. Announces Peer Reviewed Publication Highlighting Potentially Groundbreaking Discovery in Overcoming Drug Resistance in Non-Small Cell Lung Cancer
March 20, 2025
·
4 min read
1 of 19,111
Next
